ACLARION INC
ACONNASDAQπ #5044 by market capUS Equity
ββ
Quote unavailableTrack ACON
Get earnings, price moves & breaking news on Telegram
24hβ
7dβ
14dβ
30dβ
ytdβ
1yβ
π¦Market Cap
$4M
Small Cap
πRevenue Growth (YoY)
33.1%
High Growth
πGross Margin
21.8%
Moderate
π΅FCF Margin
β
βοΈP/S Ratio
42.1x
Expensive
Otter Score
β
Insufficient data
No chart data available for ACON.
Trading Snapshot
- Day Range
- β
- 52-Week Range
- $1.33 β $9.36
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 2.9M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $75,730
- Last Q Revenue
- $33,733
- P/E Ratio
- β
- P/S Ratio
- 42.1x
- EPS (TTM)
- $-7.92
- Dividend Yield
- β
- Dilution (1yr)
- +41400.5%
ACLARION INC
ACONFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$76Kβ² +65.6% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-291.3%β² +58.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$7Mβ² +27.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$7Mβ² +28.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
532Kβ² +41400.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$12Mβ² +$12M YoY
About ACLARION INC
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πQualityβ
β
β
β
β
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.